Antidepressants most prescribed during doctor and hospital visits: CDC survey

Share this article:

Antidepressants were the most commonly prescribed medications during US hospital and doctor visits, according to statistics published Friday from the US Centers for Disease Control and Prevention (CDC).

The survey examined 352 hospitals and about 1,200 physicians throughout 2005.
Of 2.4 billion drugs mentioned in patients’ medical records in 2005, 118 million were antidepressants. High blood pressure medications followed at 113 million and arthritis or headache drugs were mentioned in 110 million patient records.

The study also found that hospital and doctor visits have surged 20% in the past five years.

The report estimates that 1.2 billion visits were made to hospitals, emergency rooms and physicians’ offices in 2005.

The full CDC report is available online at http://www.cdc.gov/nchs/data/as/ad388.pdf.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...